Gene-Disorder Association · Article
Gene
TP53Tumor Protein P53
×
First reported
1992
Supporting publications
94
Manually curatedApproved treatment annotated
Association Review
In brief
The association between TP53 (Tumor Protein P53) and Endometrial Cancer is reported, with clinical genetic testing available.
Sources
1
Clinical variants
1
Symptoms
2
Compounds
3
Trials
160of 6,781 via TP53 compounds
Publications
94
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources
1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
3 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access
04
Endometrial Cancer
The disorder
20 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
Phenotype
Clinical features
1 clinical feature
The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.
Request access
06
ClinVar and variant evidence
Genetic basis
1 clinical variant
ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.
Request access
07
Population genetics
GWAS signals
1 GWAS phenotype
Gene-associated GWAS phenotypes matching the disorder, with best SNP, score, risk-allele frequency and effect size.
Request access
08
Mechanism overlap
Shared mechanisms
2 shared pathways
Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.
Request access
09
Interventions
Therapeutics
3 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
10
Human studies
Clinical trials
6,781 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
94 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
12
Provenance
References & sources
22 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access